Published date: 4 March 2021
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Medical equipments - 33100000
Medical consumables - 33140000
Diagnostic kits - 33141625
Biomedical equipment - 38434540
Repair and maintenance services of medical equipment - 50421000
Location of contract
Any region
Value of contract
£7,143,000
Procurement reference
tender_198620/930917
Published date
4 March 2021
Closing date
14 January 2020
Closing time
12pm
Contract start date
22 February 2021
Contract end date
21 February 2025
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas:
- Solid organ transplantation and clinical advice for donor selection
- Haematopoietic stem cell transplantation and clinical advice for donor selection
- Blood transfusion and transfusion reactions (SHOT)
- Platelet refractoriness and provision of HLA/ HPA selected components
- Platelet immunology
- Granulocyte immunology
- Immunogenetics including diagnostic testing and pharmacogenetics
- Haematopoietic stem cell donor registry typing
NHSBT require Human Leukocyte Antigen (HLA) antibody detection and definition systems. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA antibody detection and definition in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve.
We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve.
For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement.
The Framework Agreement was awarded for 4 years and divided into lots as follows:
Lot 1 - HLA Antibody Detection and Definition Systems - awarded to VH Bio Ltd and Immucor
Lot 2 - Maintenance of Existing Luminex Systems - awarded to Immucor
Award information
Awarded date
11 February 2021
Contract start date
22 February 2021
Contract end date
21 February 2025
Total value of contract
£7,143,000
This contract was awarded to 2 suppliers.
VH Bio Ltd
Address
Unit 11b Station Approach, Team Valley Trading Estate, Gateshead, NE11 0ZF
Reference
No reference - other
Supplier is SME?
No
Supplier is VCSE?
No
Immucor
Address
2 Cranbrook Way, Solihull Business Park, Solihull, West Midlands B90 4GT
Reference
No reference - other
Supplier is SME?
No
Supplier is VCSE?
No
About the buyer
Address
500 North Bristol Park
Bristol
BS43 7QH
England
Share this notice
Closing: 14 January 2020, 12pm